Adapting care for older cancer patients during the COVID-19 pandemic
The COVID-19 pandemic poses a barrier to equal and evidence-based management of cancer in older adults. The International Society of Geriatric Oncology (SIOG) formed a panel of experts to develop consensus recommenda-tions on the implications of the pandemic on several aspects of cancer care in this age group including geriatric assessment (GA), surgery, radiotherapy, systemic treatment, palliative care and research.
Age and cancer diagnosis are significant predictors of adverse outcomes of the COVID-19 infection. In this setting, GA is particularly valuable to drive decision-making. GA may aid estimating physiologic reserve and adaptive ca-pability, assessing risk-benefits of either providing or temporarily withholding treatments, and determining pa-tient preferences to help inform treatment decisions. In a resource-constrained setting, geriatric screening tools may be administered remotely to identify patients requiring comprehensive GA. Tele-health is also crucial to en-sure adequate continuity of care and minimize the risk of infection exposure.
Recommendations on the rollout of COVID-19 vaccines among older adults with cancer
The COVID-19 pandemic continues to negatively impact our society. Older adults are at increased risk of morbidity and mortality. People who are frail, living in residential care facility, and/or with comorbidities, including cancer are disproportionately disadvantaged. To reduce the risk of infection among older adults with cancer, several anticancer therapies have been prioritized, delayed, de-escalated, or omitted based on clinical need. However, public health interventions remain critical to mitigate transmission and minimize adverse outcomes. Of these, mass immunization is perhaps a more effective preventive health measure and potentially a key exit strategy from this crisis.